Clinical Trial Update: Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion and results posting of a Phase 1/2 study evaluating paroxetine and fluconazole for HIV-associated neurocogniti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Neurocognitive Disorder

Drugs mentioned

• Fluconazole (Fluconazole)
• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Johns Hopkins University | Conditions: HIV Associated Neurocognitive Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-12